Short-term outcome after transcatheter aortic valve replacement with a novel balloon-expandable valve

OBJECTIVES: Transcatheter aortic valve replacement (TAVR) has been expanding rapidly with numerous transcatheter heart valve (THV) systems currently available. The Myval balloon-expandable (BE) valve (Meril Life Sciences Pvt. Ltd., India) is a novel THV system indicated for the treatment of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Halim, J., den Heijer, P., van den Branden, B., Meuwissen, M., Vos, J., Schölzel, B., IJsselmuiden, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667167/
https://www.ncbi.nlm.nih.gov/pubmed/36480146
http://dx.doi.org/10.1007/s12471-022-01738-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667167/
https://www.ncbi.nlm.nih.gov/pubmed/36480146
http://dx.doi.org/10.1007/s12471-022-01738-z

Ejemplares similares